Denosumab-desu
Generic Name: denosumab-desu
Manufactured by ACCORD BIOPHARMA INC.. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: denosumab-desu (120MG/1.7ML). Application: BLA761424.
Overview
Manufactured by ACCORD BIOPHARMA INC.. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: denosumab-desu (120MG/1.7ML). Application: BLA761424.
Dosage
Available as injectable for subcutaneous use.
Related Medications
Lamivudine Oral
lamivudine oral
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
11 DESCRIPTION Lamivudine (also known as 3TC) is a synthetic nucleoside analogue with activity against HIV-1 and HBV. The chemical name of lamivudine is (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one. Lamivudine is the (-)enantiomer of a dideoxy analogue of cytidine. Lamivudine has also been referred to as (-)2′,3′-dideoxy, 3′-thiacytidine. It has a molecular formula of C 8 H 11 N 3 O 3 S and a molecular weight of 229.3 g per mol.
Selegiline Hcl
selegiline hcl
Dosage form: POWDER. Active ingredients: SELEGILINE HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Roflumilast
roflumilast
Phosphodiesterase 4 Inhibitor [EPC]
11 DESCRIPTION The active ingredient in roflumilast tablets is roflumilast. Roflumilast and its active metabolite (roflumilast N-oxide) are selective phosphodiesterase 4 (PDE4) inhibitors. The chemical name of roflumilast is N-(3,5-dichloropyridin-4-yl)-3-cy-clopropylmethoxy-4-difluoromethoxy-benzamide. Its empirical formula is C 17 H 14 Cl 2 F 2 N 2 O 3 and the molecular weight is 403.22.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.